Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Büchsel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Hamostaseologie|February 1, 2022
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding DefectSalome Fels, Doris Boeckelmann, Hannah Glonnegger, et al.
Diagnostic Microbiology and Infectious Disease|June 26, 2016
A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemiaMartin Büchsel, Lars Pletschen, Michael Fleiner, et al.
Regional Anesthesia and Pain Medicine|January 27, 2023
Residual anti-Xa activity in plasma of patients presenting for electively planned neuraxial regional anesthesiaJulian Knoerlein, Philipp Brodbeck, Martin Büchsel, et al.
Critical Care Medicine|March 2, 2022
Acquired von Willebrand Syndrome and Desmopressin Resistance During Venovenous Extracorporeal Membrane Oxygenation in Patients With COVID-19: A Prospective Observational StudyJohannes Kalbhenn, Hannah Glonnegger, Martin Büchsel, et al.
BMC Pediatrics|August 14, 2022
Emicizumab in children: bleeding episodes and outcome before and after transition to EmicizumabHannah Glonnegger, Felicia Andresen, Friedrich Kapp, et al.
Hamostaseologie|November 10, 2022
Laboratory Findings, Medical Imaging, and Clinical Outcome in Children with Cerebral Sinus Venous ThrombosisHannah Glonnegger, Nicole Glatthaar, Matthias Eckenweiler, et al.
Hamostaseologie|October 9, 2025
Laboratory Monitoring in Patients Receiving EmicizumabJens Müller, Martin Büchsel, Olga Oleshko, et al.
Thrombosis Journal|January 10, 2023
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome - an observational studyMartin Büchsel, Ulrich Geisen, Clara Beckenkamp, et al.
Hamostaseologie|December 22, 2022
Reference Intervals in Coagulation AnalysisJens Müller, Martin Büchsel, Michael Timme, et al.
Hamostaseologie|December 23, 2021
Type 2B von Willebrand Disease: Early Manifestation as Neonatal ThrombocytopeniaDavid Kranzhöfer, Anna Pavlova, Hendryk Schneider, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Hamostaseologie|February 1, 2022
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding DefectSalome Fels, Doris Boeckelmann, Hannah Glonnegger, et al.
Diagnostic Microbiology and Infectious Disease|June 26, 2016
A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemiaMartin Büchsel, Lars Pletschen, Michael Fleiner, et al.
Regional Anesthesia and Pain Medicine|January 27, 2023
Residual anti-Xa activity in plasma of patients presenting for electively planned neuraxial regional anesthesiaJulian Knoerlein, Philipp Brodbeck, Martin Büchsel, et al.
Critical Care Medicine|March 2, 2022
Acquired von Willebrand Syndrome and Desmopressin Resistance During Venovenous Extracorporeal Membrane Oxygenation in Patients With COVID-19: A Prospective Observational StudyJohannes Kalbhenn, Hannah Glonnegger, Martin Büchsel, et al.
BMC Pediatrics|August 14, 2022
Emicizumab in children: bleeding episodes and outcome before and after transition to EmicizumabHannah Glonnegger, Felicia Andresen, Friedrich Kapp, et al.
Hamostaseologie|November 10, 2022
Laboratory Findings, Medical Imaging, and Clinical Outcome in Children with Cerebral Sinus Venous ThrombosisHannah Glonnegger, Nicole Glatthaar, Matthias Eckenweiler, et al.
Hamostaseologie|October 9, 2025
Laboratory Monitoring in Patients Receiving EmicizumabJens Müller, Martin Büchsel, Olga Oleshko, et al.
Thrombosis Journal|January 10, 2023
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome - an observational studyMartin Büchsel, Ulrich Geisen, Clara Beckenkamp, et al.
Hamostaseologie|December 22, 2022
Reference Intervals in Coagulation AnalysisJens Müller, Martin Büchsel, Michael Timme, et al.
Hamostaseologie|December 23, 2021
Type 2B von Willebrand Disease: Early Manifestation as Neonatal ThrombocytopeniaDavid Kranzhöfer, Anna Pavlova, Hendryk Schneider, et al.
Pageof 2